Acanthamoeba Keratitis Associated With Tap Water Use During Contact Lens Cleaning Manufacturer Guidelines Need to Change John E. Legarreta, M.D.; Amy C. Nau, O.D.; Deepinder K. Dhaliwal, MD, L.Ac ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) today revealed it has approved Akantior (polihexanide) to treat acanthamoeba keratitis (AK). The approval was granted to Italian ...

Acanthamoeba keratitis inflammation is worsened immune-mediated factors that are influenced by patient genetic variability, inadequate treatment, and pathogenicity of the Acanthamoeba strain, ...

A novel artificial intelligence (AI) model shows good accuracy for diagnosing Acanthamoeba keratitis based on in vivo confocal microscopy images, according to a retrospective cohort study published in ...

Professor John Dart from UCL Institute of Ophthalmology and Moorfields was the principal investigator of a Phase 3 clinical trial. He said: ‘This breakthrough offers significant improvement over ...

Acanthamoeba keratitis appeared to be a relatively rare disorder with similar incidence around the world, according to a study published in Ophthalmology. “Although there have been some studies ...

Acanthamoeba keratitis (AK) is a low-incidence disorder among the general population, research published in Ophthalmology shows. However, the number of AK cases is projected to increase significantly ...

According to my 35 years’ experience in Egypt, if the population understands this phrase, acanthamoeba keratitis can become a historical disease. Acanthamoeba keratitis became well-known in the 1980’s ...

Acanthamoeba keratitis is an eye infection caused by an Acanthamoeba amoeba. The microorganism infects the cornea, leading to possible vision loss and blindness. The infection, which usually ...

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has backed approval for Akantior (polihexanide), a potential first medicine to treat acanthamoeba keratitis.

The CHMP positive opinion is based on positive data from the comprehensive development program including a Phase 1 and the largest Phase 3 trial in AK to date. The Phase 3 pivotal was a randomized, ...